Home > Research > Publications & Outputs > GLP-1 receptor agonists for Parkinson's disease...

Research

Associated organisational unit

Electronic data

  • CD012990

    Rights statement: This is the Publisher version of record of the following article: Mulvaney CA, Duarte GS, Menon S, Handley J, Emsley HC. GLP-1 receptor agonists for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012990. DOI: 10.1002/14651858.CD012990 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012990 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

    Final published version, 221 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

GLP-1 receptor agonists for Parkinson's disease (Protocol)

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

GLP-1 receptor agonists for Parkinson's disease (Protocol). / Mulvaney, Caroline A.; Duarte, Gonçalo S.; Menon, Suresh et al.
In: Cochrane Database of Systematic Reviews, Vol. 2018, No. 3, 29.03.2018, p. 1-14.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Mulvaney, CA, Duarte, GS, Menon, S, Handley, J & Emsley, H 2018, 'GLP-1 receptor agonists for Parkinson's disease (Protocol)', Cochrane Database of Systematic Reviews, vol. 2018, no. 3, pp. 1-14. https://doi.org/10.1002/14651858.CD012990

APA

Mulvaney, C. A., Duarte, G. S., Menon, S., Handley, J., & Emsley, H. (2018). GLP-1 receptor agonists for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews, 2018(3), 1-14. https://doi.org/10.1002/14651858.CD012990

Vancouver

Mulvaney CA, Duarte GS, Menon S, Handley J, Emsley H. GLP-1 receptor agonists for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews. 2018 Mar 29;2018(3):1-14. doi: 10.1002/14651858.CD012990

Author

Mulvaney, Caroline A. ; Duarte, Gonçalo S. ; Menon, Suresh et al. / GLP-1 receptor agonists for Parkinson's disease (Protocol). In: Cochrane Database of Systematic Reviews. 2018 ; Vol. 2018, No. 3. pp. 1-14.

Bibtex

@article{bb4d0515328f4acca2cca871ba73ddfd,
title = "GLP-1 receptor agonists for Parkinson's disease (Protocol)",
abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To evaluate the effectiveness and safety of GLP-1 receptor agonists for Parkinson{\textquoteright}s disease.We will differentiate, as far as possible between neuroprotective and symptomatic effects.",
author = "Mulvaney, {Caroline A.} and Duarte, {Gon{\c c}alo S.} and Suresh Menon and Joel Handley and Hedley Emsley",
note = "This is the Publisher version of record of the following article: Mulvaney CA, Duarte GS, Menon S, Handley J, Emsley HC. GLP-1 receptor agonists for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012990. DOI: 10.1002/14651858.CD012990 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012990 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.",
year = "2018",
month = mar,
day = "29",
doi = "10.1002/14651858.CD012990",
language = "English",
volume = "2018",
pages = "1--14",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

RIS

TY - JOUR

T1 - GLP-1 receptor agonists for Parkinson's disease (Protocol)

AU - Mulvaney, Caroline A.

AU - Duarte, Gonçalo S.

AU - Menon, Suresh

AU - Handley, Joel

AU - Emsley, Hedley

N1 - This is the Publisher version of record of the following article: Mulvaney CA, Duarte GS, Menon S, Handley J, Emsley HC. GLP-1 receptor agonists for Parkinson's disease (Protocol). Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012990. DOI: 10.1002/14651858.CD012990 which has been published in final form at http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD012990 This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

PY - 2018/3/29

Y1 - 2018/3/29

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To evaluate the effectiveness and safety of GLP-1 receptor agonists for Parkinson’s disease.We will differentiate, as far as possible between neuroprotective and symptomatic effects.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To evaluate the effectiveness and safety of GLP-1 receptor agonists for Parkinson’s disease.We will differentiate, as far as possible between neuroprotective and symptomatic effects.

U2 - 10.1002/14651858.CD012990

DO - 10.1002/14651858.CD012990

M3 - Journal article

VL - 2018

SP - 1

EP - 14

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 3

ER -